Literature DB >> 21864167

Thrombopoietin-receptor agonists for primary immune thrombocytopenia.

Paul Imbach1, Mark Crowther.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864167     DOI: 10.1056/NEJMct1014202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  37 in total

1.  Bidirectional inefficacy or intolerability of thrombopoietin receptor agonists: new data and a concise review.

Authors:  Fabian Depré; Nasra Aboud; Beate Mayer; Abdulgabar Salama
Journal:  Blood Transfus       Date:  2017-01-25       Impact factor: 3.443

2.  The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura.

Authors:  Dino Veneri; Lorenza Soligo; Giovanni Pizzolo; Achille Ambrosetti
Journal:  Blood Transfus       Date:  2015-04-21       Impact factor: 3.443

Review 3.  Activity of eltrombopag in severe aplastic anemia.

Authors:  Phillip Scheinberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 4.  Activity of eltrombopag in severe aplastic anemia.

Authors:  Phillip Scheinberg
Journal:  Blood Adv       Date:  2018-11-13

5.  Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.

Authors:  Reiko Watanabe; Takayuki Tabayashi; Tatsuki Tomikawa; Morihiko Sagawa; Tomoe Anan-Nemoto; Yuta Kimura; Yasuyuki Takahashi; Michihide Tokuhira; Satoshi Otaki; Hidenori Oi; Makoto Sawano; Satoshi Sugiyama; Masahiro Kizaki
Journal:  Int J Hematol       Date:  2016-10-05       Impact factor: 2.490

Review 6.  Eltrombopag: Role in Cytopenias Following Hematopoietic Stem Cell Transplantation.

Authors:  Ram Vasudevan Nampoothiri; Rajat Kumar
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-24       Impact factor: 0.900

Review 7.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

8.  Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy.

Authors:  Karen K W Wang; Cathy Charles; Nancy M Heddle; Emmy Arnold; Laura Molnar; Donald M Arnold
Journal:  Health Expect       Date:  2012-08-07       Impact factor: 3.377

9.  Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase®.

Authors:  Thi-Thanh Loan Nguyen; Aurore Palmaro; François Montastruc; Maryse Lapeyre-Mestre; Guillaume Moulis
Journal:  Drug Saf       Date:  2015-12       Impact factor: 5.606

10.  Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag.

Authors:  Phillip Scheinberg; Cristiane Carvalho Singulane; Luis Sergio Guedes Barbosa; Morton Scheinberg
Journal:  Clin Rheumatol       Date:  2014-04-17       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.